Literature DB >> 9699945

The chromatin pattern of cell nuclei is of prognostic value for renal cell carcinomas.

C François1, M Remmelink, M Petein, R van Velthoven, A Danguy, E Wespes, I Salmon, R Kiss, C Decaestecker.   

Abstract

Using a series of 105 renal cell carcinomas (RCCs) we investigated whether features quantitatively describing the appearance of Feulgen-stained nuclei and, more particularly, of their chromatin (on the basis of computer-assisted microscopy) can contribute any significant prognostic information. Thirty morphonuclear and 8 nuclear DNA content-related variables were thus generated. The actual prognostic values of this set of cytometric variables was compared (by means of discriminant statistical analysis) to conventional diagnostic and/or prognostic markers including histopathological grades, tumour invasion levels and the presence or absence of metastases. We obtained complete clinical follow-ups for 49 of the 105 RCC patients under study, making it possible to define a subset of patients with a bad prognosis (i.e., who died in the 12 months following nephrectomy) and a subset of patients with a good prognosis (i.e., who survived at least 24 months following nephrectomy). An original method of data analysis related to artificial intelligence (decision tree induction) enabled a strong prognostic model to be set up. In the case of 10 new patients, this model identified all the dead patients as having a bad survival status, with a total of 8 correct predictions. Another prognostic model similarly generated enabled the correct predictions to be confirmed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699945      PMCID: PMC4611130          DOI: 10.1155/1998/485143

Source DB:  PubMed          Journal:  Anal Cell Pathol        ISSN: 0921-8912            Impact factor:   2.916


  1 in total

1.  Three-dimensional texture analysis of renal cell carcinoma cell nuclei for computerized automatic grading.

Authors:  T Y Kim; H J Choi; H G Hwang; H K Choi
Journal:  J Med Syst       Date:  2009-04-08       Impact factor: 4.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.